Thymomas in Patients with Myasthenia Gravis
Thymomas in Patients with Myasthenia Gravis
复制标题
重症肌无力患者的胸腺瘤
DOI：
10.1097/00000658-197808000-00008
复制
发表时间：
1978
影响因子：
9
通讯作者：
A. Bender
中科院分区：
文献类型：
--
作者：
G. Slater;A. Papatestas;G. Genkins;P. Kornfeld;S. Horowitz;A. Bender
本文回顾了141例重症肌无力合并胸腺瘤患者的临床资料。本组非侵袭性肿瘤69例，侵袭性肿瘤52例。所有患者的五年生存率为60%，侵袭性组的预后比非侵入性组差。整个组(侵袭性和非侵袭性)肌无力患者的缓解率非常低(7%)。虽然这一系列患者的总体存活率相对较高，但人们认为，如果早期诊断，采取更积极的手术方法，他们的预后会更好。
The records of 141 patients with myasthenia gravis who had thymomas were reviewed. In this series there were 69 noninvasive tumors and 52 invasive tumors. The five year survival for all patients was 60%, with the invasive group demonstrating a poorer prognosis than the noninvasive. The remission rates for the whole group (both invasive and noninvasive) of myasthenics was quite low (7%). Although the overall survival of this series of patients was relatively high, it is felt that by earlier diagnosis and a more aggressive surgical approach their prognosis will be even better.